Brain Cancer Clinical Trials in New York

Showing 201-220 of 237 trials

A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme

NCT01268566

The primary objective of this Phase II study is to evaluate the progression-free survival at 6 months in adult subjects with a first recurrence of Glioblastoma Multiforme who are treated with MEDI-575.

Glioblastoma Multiforme

MedImmune LLC62 participantsStarted Jan 2011

Tucson, Arizona, United States • Los Angeles, California, United States • Stanford, California, United States +9 more locations

COMPLETEDPhase 2< 1 mile

Pazopanib in Treating Patients With Recurrent Glioblastoma

NCT00459381

This phase II trial is studying the side effects and how well pazopanib works in treating patients with recurrent glioblastoma. Pazopanib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor

Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more

National Cancer Institute (NCI)35 participantsStarted May 2007

Los Angeles, California, United States • San Francisco, California, United States • Bethesda, Maryland, United States +6 more locations

A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme

Pazopanib in Treating Patients With Recurrent Glioblastoma

Brain Cancer Trials in Other Cities

MK-2206 for Recurrent Malignant Glioma

Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma

A Feasibility Study of Image Guided Noninvasive Single Fraction Stereotactic Radiosurgery for the Treatment of Brain Metastases

Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma

Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma

Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma

A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant Glioma

Gene Testing to Help in the Diagnosis and Treatment of Childhood Brain Tumors

Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma

Erlotinib and Sorafenib in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors

Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Phase I/II Trial of Intracerebral IL13-PE38QQR Infusions in Pediatric Patients With Recurrent Malignant Glioma

LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma

A Study of GDC-0084 in Patients With Progressive or Recurrent High-Grade Glioma

AMG 595 First-in-Human in Recurrent Gliomas

A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma

Short Course vs. Standard Course Radiotherapy in Elderly and/or Frail Patients With Glioblastoma Multiforme

Other Conditions in New York